- Home
- QVCGA vs BNR Comparison
QVCGA vs BNR Comparison
Compare QVCGA & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QVCGA
- BNR
- Stock Information
- Founded
- QVCGA 1991
- BNR 2014
- Country
- QVCGA United States
- BNR China
- Employees
- QVCGA N/A
- BNR N/A
- Industry
- QVCGA
- BNR Medical Specialities
- Sector
- QVCGA
- BNR Health Care
- Exchange
- QVCGA NYSE
- BNR Nasdaq
- Market Cap
- QVCGA 25.6M
- BNR 38.3M
- IPO Year
- QVCGA N/A
- BNR 2020
- Fundamental
- Price
- QVCGA $4.16
- BNR $5.81
- Analyst Decision
- QVCGA
- BNR
- Analyst Count
- QVCGA 0
- BNR 0
- Target Price
- QVCGA N/A
- BNR N/A
- AVG Volume (30 Days)
- QVCGA 648.6K
- BNR 53.5K
- Earning Date
- QVCGA 08-07-2025
- BNR 08-21-2025
- Dividend Yield
- QVCGA N/A
- BNR N/A
- EPS Growth
- QVCGA N/A
- BNR N/A
- EPS
- QVCGA N/A
- BNR N/A
- Revenue
- QVCGA $9,800,000,000.00
- BNR $72,112,038.00
- Revenue This Year
- QVCGA $2.89
- BNR $136.32
- Revenue Next Year
- QVCGA $0.45
- BNR N/A
- P/E Ratio
- QVCGA N/A
- BNR N/A
- Revenue Growth
- QVCGA N/A
- BNR 0.53
- 52 Week Low
- QVCGA $2.27
- BNR $2.18
- 52 Week High
- QVCGA $37.27
- BNR $9.48
- Technical
- Relative Strength Index (RSI)
- QVCGA N/A
- BNR 56.55
- Support Level
- QVCGA N/A
- BNR $6.71
- Resistance Level
- QVCGA N/A
- BNR $9.48
- Average True Range (ATR)
- QVCGA 0.00
- BNR 0.85
- MACD
- QVCGA 0.00
- BNR 0.17
- Stochastic Oscillator
- QVCGA 0.00
- BNR 34.46
About QVCGA QVC GROUP INC
QVC Group Inc is a live social shopping company with six retail brands QVC, HSN, Ballard Designs, Frontgate, Garnet Hill, Grandin Road, and other minority interests. QVC offers assortment of ,quality merchandise and classifies its products into six groups: home, apparel, beauty, accessories, electronics and jewelry. The company has three reportable segments: QxH, QVC International, and CBI. Majority of revenue is from Home products, from QxH segment. Company also operates in Japan, Germany and Other foreign countries.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.